Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for ...
News-Medical.Net on MSN
AI language models actually help in digestive disease care
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...
The JASMINE trial showed nipocalimab's efficacy in SLE, meeting primary and secondary endpoints, including steroid sparing ...
Early intensive BP control significantly reduces cardiovascular risk in older patients compared with delayed initiation of treatment.
To make it easier for children with asthma to receive care at school, a new study will assess the impact of making the ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
With a $25 million grant, the Penn team will launch a randomized controlled trial to see if their game reduces the risk of heart events.
Major depressive disorder (MDD) is a widespread and serious mental health condition that affects how people think, feel, and ...
A substantial percentage of adults with gout attribute their condition to lifestyle factors, which may lead to worse health outcomes and poorer SU control.
Why lasting weight maintenance requires more than calorie control, integrating diet quality, movement, circadian biology, ...
Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback